P46 SEER-MEDICARE DATABASE: REAL-WORLD TREATMENTS AND OUTCOMES IN PATIENTS WITH LENALIDOMIDE-REFRACTORY RELAPSED MULTIPLE MYELOMA TREATED WITH 1–3 PRIOR LINES OF THERAPY, INCLUDING...

por Einsele, H., Dhakal, B., Potluri, R., Schecter, J., Deraedt, W., Lendvai, N., Slaughter, A., Lonardi, C., Nair, S., He, J., Voelker, J., Cost, P., Valluri, S., Yalniz, F., Pacaud, L., Yong, K.
Publicado 2023

P899: REAL-WORLD ASSESSMENT OF TREATMENT PATTERNS AND OUTCOMES IN PATIENTS WITH LENALIDOMIDE-REFRACTORY RELAPSED/REFRACTORY MULTIPLE MYELOMA FROM THE OPTUM DATABASE

por Dhakal, B., Einsele, H., Potluri, R., Schecter, J., Deraedt, W., Lendvai, N., Slaughter, A., Lonardi, C., Nair, S., He, J., Joseph, N., Cost, P., Valluri, S., Yalniz, F., Pacaud, L., Yong, K.
Publicado 2022

P35 ANALYSIS OF DARATUMUMAB CLINICAL TRIALS: CHARACTERISTICS AND OUTCOMES IN PATIENTS WITH LENALIDOMIDE-REFRACTORY RELAPSED/REFRACTORY MULTIPLE MYELOMA TREATED WITH 1-3 PRIOR LINES...

por Einsele, H., Dhakal, B., Schecter, J. M., Roccia, T., Deraedt, W., Lendvai, N., Slaughter, A., Lonardi, C., Connors, K., Qi, K., Londhe, A., Carson, R., Voelker, J., Cost, P., Valluri, S., Florendo, E., Pacaud, L., Yong, K.
Publicado 2023

P08: CARTITUDE-2 UPDATE: CILTACABTAGENE AUTOLEUCEL, A B-CELL MATURATION ANTIGEN–DIRECTED CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY, IN LENALIDOMIDE-REFRACTORY PATIENTS WITH PROGRESS...

por Einsele, H, Cohen, AD, Delforge, M, Hillengass, J, Goldschmidt, H, Weisel, K, Raab, M-S, Scheid, C, Schecter, JM, De Braganca, KC, Varsos, H, Yeh, T-M, Wang, L, Vogel, M, Corsale, C, Akram, M, Pacaud, L, Nesheiwat, T, Agha, M, Cohen, YC
Publicado 2022

B07: SAFETY AND EFFICACY OF CILTACABTAGENE AUTOLEUCEL, A CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY DIRECTED AGAINST B-CELL MATURATION ANTIGEN IN PATIENTS WITH MULTIPLE MYELOMA AND E...

por van de Donk, NWCJ, Delforge, M, Agha, M, Cohen, AD, Cohen, YC, Hillengass, J, Anguille, S, Kerre, T, Roeloffzen, W, Schecter, JM, De Braganca, KC, Varsos, H, Wang, L, Vogel, M, Zudaire, E, Corsale, C, Akram, M, Geng, D, Nesheiwat, T, Pacaud, L, Sonneveld, P, Zweegman, S
Publicado 2022

P971: ADJUSTED COMPARISON OF PATIENT REPORTED OUTCOMES FROM CARTITUDE-1 AND LOCOMMOTION COMPARING CILTACABTAGENE AUTOLEUCEL VERSUS REAL WORLD CLINICAL PRACTICE IN TRIPLE-CLASS EXPO...

por Weisel, K., Mateos, M.-V., Vincent, L., Martin, T., Berdeja, J. G., Jakubowiak, A., Jagannath, S., Lin, Y., Thilakarathne, P., Ghilotti, F., Diels, J., Haefliger, B., Hague, C., Gonzalez, A., Schecter, J. M., Gries, K. S., Strulev, V., Nesheiwat, T., Pacaud, L., Einsele, H., Moreau, P.
Publicado 2022

P959: CILTACABTAGENE AUTOLEUCEL IN LENALIDOMIDE-REFRACTORY PATIENTS WITH PROGRESSIVE MULTIPLE MYELOMA AFTER 1-3 PRIOR LINES OF THERAPY: CARTITUDE-2 BIOLOGICAL CORRELATIVE ANALYSES...

por Hillengass, J., Cohen, A. D., Delforge, M., Einsele, H., Goldschmidt, H., Weisel, K., Raab, M.-S., Scheid, C., Schecter, J. M., De Braganca, K. C., Varsos, H., Yeh, T.-M., Mistry, P., Roccia, T., Corsale, C., Akram, M., Pacaud, L., Nesheiwat, T., Agha, M., Cohen, Y. C.
Publicado 2022

P961: CILTACABTAGENE AUTOLEUCEL, A BCMA-DIRECTED CAR-T CELL THERAPY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: 2-YEAR POST LPI RESULTS FROM THE PHASE 1B/2 CARTITUDE-1...

por Lin, Y., Martin, T., Berdeja, J. G., Jakubowiak, A., Agha, M., Cohen, A. D., Deol, A., Htut, M., Lesokhin, A., Munshi, N. C., O’Donnell, E., Jackson, C. C., Yeh, T.-M., Banerjee, A., Zudaire, E., Madduri, D., Zhou, C., Pacaud, L., Usmani, S. Z., Jagannath, S.
Publicado 2022

P23 EMAGINE/CARTITUDE-6: A RANDOMIZED PHASE 3 STUDY OF DVRD FOLLOWED BY CILTACABTAGENE AUTOLEUCEL VERSUS DVRD FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLANT IN TRANSPLANT-ELIGIBLE PAT...

por Broijl, A., San-Miguel, J., Suzuki, K., Krishnan, A., van de Donk, N., Cook, G., Jakubowiak, A., Madduri, D., Afifi, S., Stevens, A., Schecter, J., Deraedt, W., Kuppens, S., Mistry, P., Pacaud, L., Boccadoro, M., Gay, F., Mina, R., Rasche, L., Moreau, P., Mateos, M., Einsele, H., Sonneveld, P.
Publicado 2023

B05: RESULTS FROM A META-ANALYSIS OF CILTACABTAGENE AUTOLEUCEL COMPARED TO PHYSICIAN’S CHOICE OF TREATMENT IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA

por Gay, F, Berdeja, JG, De Stefano, V, Hari, P, Hooper, B, Haltner, A, Kumar, S, Martin, T, Mateos, M-V, Moreau, P, Rosta, E, Samjoo, IA, Usmani, SZ, Weisel, K, Jackson, CC, Olyslager, Y, Schecter, JM, Vogel, M, Garrett, A, Lee, S, Nesheiwat, T, Pacaud, L, Zhou, C, Valluri, S, Costa, LJ, Lin, Y
Publicado 2022

B09 CARTITUDE-2 COHORT B 18-MONTH FOLLOW-UP: CILTACABTAGENE AUTOLEUCEL (CILTA-CEL), A BCMA-DIRECTED CAR-T CELL THERAPY, IN PATIENTS WITH MULTIPLE MYELOMA (MM) AND EARLY RELAPSE AFT...

por Zweegman, S., Agha, M., Cohen, A.D., Cohen, Y.C., Anguille, S., Kerre, T., Roeloffzen, W., Madduri, D., Schecter, J.M., De Braganca, K.C., Jackson, C.C., Varsos, H., Mistry, P., Roccia, T., Xu, X., Li, K., Zudaire, E., Corsale, C., Akram, M., Geng, D., Pacaud, L., Sonneveld, P., van de Donk, N.
Publicado 2023

P28 EFFICACY AND SAFETY OF CILTACABTAGENE AUTOLEUCEL (CILTA-CEL) IN PATIENTS WITH PROGRESSIVE MULTIPLE MYELOMA (MM) AFTER EXPOSURE TO NON-CELLULAR ANTI-B-CELL MATURATION ANTIGEN (B...

por van de Donk, N., Mateos, M.-V., Cohen, Y.C., Rodriguez-Otero, P., Paiva, B., Cohen, A.D., Martin, T., Suvannasankha, A., Madduri, D., Corsale, C., Schecter, J.M., De Braganca, K.C., Jackson, C.C., Varsos, H., Deraedt, W., Roccia, T., Mistry, P., Xu, X., Li, K., Zudaire, E., Akram, M., Pacaud, L., Avivi, I., San-Miguel, J.
Publicado 2023

Joint adolescent–adult early phase clinical trials to improve access to new drugs for adolescents with cancer: proposals from the multi-stakeholder platform—ACCELERATE

por Gaspar, N, Marshall, L V, Binner, D, Herold, R, Rousseau, R, Blanc, P, Capdeville, R, Carleer, J, Copland, C, Kerloeguen, Y, Norga, K, Pacaud, L, Sevaux, M -A, Spadoni, C, Sterba, J, Ligas, F, Taube, T, Uttenreuther-Fischer, M, Chioato, S, O'Connell, M A, Geoerger, B, Blay, J -Y, Soria, J C, Kaye, S, Wulff, B, Brugières, L, Vassal, G, Pearson, A D J
Publicado 2018